CLL-specific scientific studies & literature related to COVID-19

In this section you will find a compilation of scientific studies and articles from the literature on COVID-19 relevant to CLL patients.

If you know about any current or published study on CLL and COVID-19, please let us know by sending us an email.

First published: 18 May 2020

Clinical Outcome of Coronavirus Disease 2019 in Haemato‐oncology Patients

James A. Aries, Jeffrey K. Davies, Rebecca L. Auer, Simon L. Hallam, Silvia Montoto, Matthew Smith, Belen Sevillano, Vanessa Foggo, Bela Wrench, Krzysztof Zegocki, Samir Agrawal, Rifca Le Dieu, Edward Truelove, Thomas Erblich, Shamzah Araf, Jessica Okosun, Heather Oakervee, Jamie D. Cavenagh, John G. Gribben, John C. Riches

Summary: The initial reports from China show that patients with cancer are over‐represented among individuals who develop severe Covid‐19 after contracting the virus.(4) Patients with haematological malignancies are expected to be at increased risk of adverse outcomes from this viral infection, due being immunosuppressed as a consequence of the underlying cancer, and from the effects of therapy. Our data demonstrate that while patients with haematological cancers have worse outcomes after Covid-19 than the background population, the majority still survive.

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/bjh.16852

Please access the full article here.

Published in Blood: 17 April 2020

The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients

Steven P Treon, Jorge Castillo, Alan P Skarbnik, Jacob D Soumerai, Irene M Ghobrial, Maria Luisa Guerrera, Kirsten E. Meid, Guang Yang

Paper from latest ASH COVID related publications.

Please access the full article here

First published: 7 May 2020

Survival study of hospitalized patients with concurrent Covid‐19 and haematological malignancies

Fernando Martín‐Moro, Juan Marquet, Miguel Piris, Berta M Michael, Adolfo J Sáez, Magdalena Corona, Carlos Jiménez, Beatriz Astibia, Irene García, Eulalia Rodríguez, Carlota García‐Hoz, Jesús Fortún‐Abete, Pilar Herrera, Javier López‐Jiménez

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/bjh.16801

Please access the full article here

First published: 30 April 2020

Management of CLL Patients Early in the COVID‐19 Pandemic: An International Survey of CLL Experts

Brian Koffman, Anthony Mato, John C. Byrd, Alexey Danilov, Brad Hedrick, Chaitra Ujjani, Lindsey Roeker, Deborah M. Stephens, Matthew S. Davids, John M. Pagel, Mazyar Shadman

You can access the full article here.

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/ajh.25851.

Published: 30 April 2020

Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia

S. Paneesha,a,b G. Pratt,a,b H. Parry,a,b and P. Mossa,b,⁎

You can access the full article here.

Published: 24 April 2020

COVID-19 in persons with haematological cancers

  • Wenjuan He, Lei Chen, Li Chen, Guolin Yuan, Yun Fang, Wenlan Chen, Di Wu, Bo Liang, Xiaoting Lu, Yanling Ma, Lei Li, Hongxiang Wang, Zhichao Chen, Qiubai Li & Robert Peter Gale

You can access the full article here.

Icons made by Freepik from www.flaticon.com
© 2020 – CLL Advocates Network
Website handcrafted by Lawrence Mouawad